Patient & Provider Perspectives on Homeopathic Treatment

病人

• 批准号: 6559618
• 负责人: IRIS Roberta BELL
• 金额: $ 18.86万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-01-01 至 2004-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6559618
• 关键词: alternative medicine; chronic disease /disorder; clinical research; data management; health care; human subject; human therapy evaluation; interview; longitudinal human study; outcomes research; psychophysiology; questionnaires

DESCRIPTION (provided by applicant): Homeopathy, a major system of care within complementary and alternative medicine (CAM) is a 200-year-old field that has to date stimulated much debate over the nature of its medicines (remedies), but little research on its diagnostic and therapeutic process as experienced by providers and patients in clinical practice. Homeopaths report that their patients undergo a broader scope and deeper quality of change in multiple dimensions than do allopathic patients. The overarching goal of this R21, 2-year exploratory proposal is to understand successful homeopathic treatment of chronic diseases in the context of previously unsuccessful homeopathic treatment, other CAM interventions, and allopathic care, from both provider and patient perspectives. The three distinct analytic design components, each with its own unique qualitative research methodologies, address: Specific Aim 1 Develop a grounded theory that explicates the delivery of care process by classical homeopathic providers with differing conventional medical and CAM professional training backgrounds. Specific Aim 2 Describe the patient's lived experience of homeopathic and other health care. Specific Aim 3 Evaluate similarities and differences in perceptions of treatment course and outcomes between patients and providers within each homeopathic orientation. Participants will include (a) classical homeopathic providers (selecting a single remedy to address the entire person as a whole system) will allopathic professional training (MD, DU, NP, PA); (b) classical homeopathic providers with CAM professional training (ND, DC, HMA, lay professional homeopaths); and (c) exemplar patients of each provider, i.e., patients with any previously established, chronic allopathic diagnosis who, in the provider's global clinical impression, have exhibited a sustained, "outstanding or extremely successful outcome in their condition" for at least 1 year follow-up. Prior research and clinical observations suggest that such patients also will have had experiences with unsuccessful homeopathic, other CAM, and allopathic treatments to compare with their currently "successful" outcomes. For the Grounded Theory component (Aim 1), providers (N=48) will undergo both individual interviews and focus groups. For the Phenomenology component (Aim 2), patients (N=48) will undergo individual interviews. For the Comparative Analysis component (Aim 3), we will evaluate both data sets to develop an explanatory model of successful homeopathic treatment. This project is part of the Pi's long-term interactive homeopathy research program on patient-centered issues and psychophysiological markers of homeopathic remedy effects. Findings from this proposed study should help clarify the proper premises and parameters on which to base future prospective qualitative and quantitative research in homeopathy.

描述（由申请人提供）：顺势疗法是补充和替代医学 (CAM) 中的一个主要护理系统，是一个拥有 200 年历史的领域，迄今为止引发了对其药物（疗法）性质的许多争论，但研究很少提供者和患者在临床实践中所经历的诊断和治疗过程。 顺势疗法患者报告说，与对抗疗法患者相比，他们的患者在多个方面经历了更广泛的范围和更深层次的变化。 这项 R21 为期 2 年的探索性提案的总体目标是从提供者和患者的角度，在先前不成功的顺势疗法、其他 CAM 干预措施和对抗疗法护理的背景下，了解慢性疾病的成功顺势疗法。三个不同的分析设计组成部分，每个组成部分都有其独特的定性研究方法，旨在解决： 具体目标 1 制定基础理论，阐明具有不同传统医学和 CAM 专业培训背景的经典顺势疗法提供者提供的护理过程。 具体目标 2 描述患者顺势疗法和其他医疗保健的生活经历。 具体目标 3 评估每个顺势疗法方向的患者和提供者之间对治疗过程和结果的看法的相似性和差异。 参与者将包括 (a) 经典顺势疗法提供者（选择单一疗法来解决整个人作为一个整体系统）将接受对抗疗法专业培训（MD、DU、NP、PA）； (b) 接受过 CAM 专业培训的经典顺势疗法提供者（ND、DC、HMA、非专业顺势疗法师）； (c) 每个提供者的典型患者，即先前已确定的慢性对抗疗法诊断的患者，在提供者的全球临床印象中，在至少一年内表现出持续的“杰出或极其成功的结果”后续行动。 先前的研究和临床观察表明，此类患者也有过顺势疗法、其他 CAM 和对抗疗法治疗不成功的经历，以与他们目前“成功”的结果进行比较。对于扎根理论部分（目标 1），提供者 (N=48) 将接受个人访谈和焦点小组访谈。 对于现象学部分（目标 2），患者 (N=48) 将接受单独访谈。 对于比较分析部分（目标 3），我们将评估两个数据集，以开发成功顺势疗法的解释模型。 该项目是 Pi 长期互动顺势疗法研究计划的一部分，该计划致力于以患者为中心的问题和顺势疗法治疗效果的心理生理标志。 这项拟议研究的结果应有助于阐明未来顺势疗法前瞻性定性和定量研究的正确前提和参数。